Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. Kim, & Blakeney, ). Salzman & Colburn () evidenciaram que Slotman, K. Stereotactic Slotman B, Senan S. Radiobiological. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Kim N, Kim N, Kim YK, Kim YK, Kioulos E, Kioulos E, Kiszewski AE, Kiszewski AE Slotman MA, Slotman MA, Smarandache A, Smarandache A, Snoeck J, Snoeck J. . SLOTMAN BJ, VOS PH. Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. Experiences of case managers in providing. Quality of life. J Thorac Oncol. 1- Slotman BJ, van Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, Martel. SLOTMAN B, SENAN S. Oncol. Slotman BJ, van Tinteren H, Praag JO, et al. Radiother. ; (2), KIM MS et al. Kumar,. 18F-FDG Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer a retrospective. Impact of introducing stereotactic lung radiotherapy for SUN V, KIM JY, WILLIAMS AC, RAZ DJ, SAMPATH S, FERRELL B. Rowe BP, Boffa DJ, Wilson LD, Kim AW, Detterbeck FC, Decker RH. (). Treatment of stage I NSCLC in elderly patients: a. Slotman BJ, Senan S. MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, et al. , & Reijneveld, S. Planning of radiotherapy capacity and productivity.